Biology: The Unity and Diversity of Life (MindTap Course List)
15th Edition
ISBN: 9781337408332
Author: Cecie Starr, Ralph Taggart, Christine Evers, Lisa Starr
Publisher: Cengage Learning
expand_more
expand_more
format_list_bulleted
Question
Chapter 36, Problem 4CT
Summary Introduction
To explain: Why erythropoietin usage enhance the performance of athletes.
Concept introduction:
Erythropoietin is an important growth factor that induces red blood cell production in blood. It is commonly called as EPO, which is actually a hormone produced by kidney. When the number of circulating RBC decreases or if the oxygen transport does not function, then the nervous system detects the change and passes the signal to liver where erythropoietin production will be increased.
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solutionStudents have asked these similar questions
One way of reducing risk of cardiovascular disease is to ensure you are getting lots of antioxidants in your diet. What antioxidants would you recommend and not recommend for someone at risk of cardiovascular disease that is also on medication that interferes with their blood’s clotting mechanism? Explain the reasons for your recommendations in one to two paragraphs. Also, list three medical conditions that can alter a person's vitamin requirements. Explain what vitamin/s would be affected and how they should alter their dietary from normal recommendations.
Which of the following statements is (are) true concerning the pathways for blood clotting?a. The intrinsic pathway takes less time than the extrinsic pathway.b. The intrinsic and extrinsic pathways require sodium.c. The intrinsic pathway is started by factors from damaged tissues.d. The intrinsic pathway requires the same clotting factors as the extrinsic pathway.e. The common pathway results in fibrin changing to fibrinogen
Hyperglycemia associated with diabetes promotes a prothrombotic state by affecting a number of different steps in the clotting pathway. Which of the following would result in
more rather than less clotting? Check all that apply. The correct answers reflect the effect of hyperglycemia on the clotting pathway!
less conversion of plasminogen to plasmin
7
000000000
abnormally low number of platelets
platelets more sensitive to thromboxane A2
elevated conversion of plasminogen to plasmin
platelets less sensitive to thromboxane A2
low sensitivity to NO and PGI2
increased prothrombin in the blood
increased amount of fibrinogen in the blood
less prothrombin in the blood
abnormally high number of platelets
less fibrinogen in the blood
high sensitivity to NO and PGI2
Chapter 36 Solutions
Biology: The Unity and Diversity of Life (MindTap Course List)
Ch. 36 - Prob. 1DAACh. 36 - Prob. 2DAACh. 36 - Risks of Hypertension Eleni Rapsomaniki and her...Ch. 36 - Prob. 1SQCh. 36 - Prob. 2SQCh. 36 - Prob. 3SQCh. 36 - Prob. 4SQCh. 36 - Prob. 5SQCh. 36 - Prob. 6SQCh. 36 - Blood flows directly from the left atrium to...
Ch. 36 - Contraction of the _________ drives blood out into...Ch. 36 - Blood pressure is highest in the _______ and...Ch. 36 - In a person at rest, the largest volume of blood...Ch. 36 - Which of the following has the thickest wall? a....Ch. 36 - Prob. 12SQCh. 36 - Which artery carries oxygen-poor blood?Ch. 36 - Prob. 14SQCh. 36 - Match the terms with their definition. _____ bone...Ch. 36 - Suppose a blood clot forms in the leg, then breaks...Ch. 36 - An atrial septal defect is a birth defect in which...Ch. 36 - Prob. 3CTCh. 36 - Prob. 4CT
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Similar questions
- What are the physiological advantages in sport due to using erythropoietin? What are the physiological consequences of using erythropoietin? Give an example of a Professional Athlete that used erythropoietin (Armstrong does not count).arrow_forwardCoumadin is an anticoagulant drug that is sometimes given to patients who have just suffered a deep vein thrombosis, a pulmonary embolism, a heart attack, or to patients with artificial heart valves. It helps reduce the chance of future clots and the further risk of embolism. The active ingredient in Coumadin is warfarin, a rat poison. How do you think the same compound can be used for these two very different purposes?arrow_forwardSome patients with hypertension are kept on a low-salt (low-sodium)diet. Propose an explanation for this therapy.arrow_forward
- Plasmin is an essential enzyme for clot breakdown (hydrolysis of fibrin protein to Fibrinogen degradation product (FDP)) as shown in the figure below. tPA is a serine protease that catalyzes the hydrolysis of plasminogen to plasmin. Cardiovascular disorders such, as heart attack and stroke are among the top ten causes of death. Stroke patients, under certain circumstances, have better outcomes when treated with tissue plasminogen activator (tPA). In humans, the PLAT gene codes the tPA protein, and is expressed only in endothelial cells that line the blood vessels. plasmin → fibrinolysis FDP tPA fibrin plasminogen a. How do you think the PLAT gene expression is specifically regulated only in the endothelial cells? Provide two specific explanations. Explain briefly. b. Considering the therapeutic potential of tPA, you and your friend want to produce a large amount of human tPA using recombinant technologies. You suggest cloning the intact human PLAT gene in bacteria to express it and…arrow_forwardWhich of the following may be used to boost red blood cell production in the bone marrow? Answers A -D A Ferrous (Fe) supplements 2+ Erythropoietin C Von Willebrand Factor (VWF) D Thrombopoietinarrow_forwardMedical evidence shows that a small change in the radius of an artery can indicate a large change in blood flow. For example, if one artery has a radius only 5% larger than another, the blood flow rate is 1.22 times as large. Further information is given in the table below. Increase in radius Times greater bloodflow rate 5% 1.22 10% 1.46 15% 1.75 20% 2.07 (a) Use the average rate of change to estimate how many times greater the blood flow rate is in an artery that has a radius 8% larger than another. (Round your answer to three decimal places.)1.364 times greater(b) Explain why if the radius is increased by 8% and then we increase the radius of the new artery by 8% again, the total increase in the radius is 16.64%. x + 8% of xx + 8/100 X xx + 0.08x = 1.08x1.08x + 8% of (1.08x)1.08x + 8/100 X (1.08x)1.08x + 0.0864x = 0.1664x = 16.64% (c) Use parts (a) and (b) to answer the following question: How many times greater is the blood flow rate in an artery that is 16.64%…arrow_forward
- Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions What is the advantage of measuring autophosphorylation of the receptor rather than phosphorylation of the substrate?arrow_forwardVascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions How would you apply a TR-FRET assay to measure the in vitro kinase activity of VEGFR-2? Describe in steps the assay design and potential readout outcome.arrow_forwardVascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions How would you determine robustness of the assay and validate the assay?arrow_forward
- Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions While setting up your experiment, you accidentally discovered autophophorylation of receptor. What observation/results led you to believe that there was autophosphorylation of the receptor?arrow_forwardVascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions If you wanted to measure the kinase activity of VEGFR-2, what are some of the conventional methods/assays you would use?arrow_forwardHyperthyroidism increases the amount of ATP formed in the individual and increases heart rate. What effect does it have on hemoglobin levels. Choose from the following: (A) hyperthyroidism would increase the number of erythrocytes and the amount of hemoglobin (B) hyperthyroidism would decrease the amount of hemoglobinarrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
- Human Physiology: From Cells to Systems (MindTap ...BiologyISBN:9781285866932Author:Lauralee SherwoodPublisher:Cengage Learning
Human Physiology: From Cells to Systems (MindTap ...
Biology
ISBN:9781285866932
Author:Lauralee Sherwood
Publisher:Cengage Learning
What is Metabolism?; Author: Stated Clearly;https://www.youtube.com/watch?v=nRq6N5NGD1U;License: Standard youtube license